BR0106681A - Fórmula pediátrica e métodos para prover nutrição a pacientes pediátricos e para melhorar tolerância em pacientes pediátricos - Google Patents

Fórmula pediátrica e métodos para prover nutrição a pacientes pediátricos e para melhorar tolerância em pacientes pediátricos

Info

Publication number
BR0106681A
BR0106681A BR0106681-1A BR0106681A BR0106681A BR 0106681 A BR0106681 A BR 0106681A BR 0106681 A BR0106681 A BR 0106681A BR 0106681 A BR0106681 A BR 0106681A
Authority
BR
Brazil
Prior art keywords
pediatric
grams
formula
milligrams
methods
Prior art date
Application number
BR0106681-1A
Other languages
English (en)
Inventor
Marlene W Borschel
Steven T Luebbers
Cynthia J Black
Daniel L Mckamy
Timothy Costigan
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23980707&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0106681(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of BR0106681A publication Critical patent/BR0106681A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/269—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
    • A23L29/27—Xanthan not combined with other microbial gums
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/801—Pediatric

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Pediatric Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

"FORMULA PEDIáTRICA E MéTODOS PARA PROVER NUTRIçãO A PACIENTES PEDIáTRICOS E PARA MELHORAR TOLERâNCIA EM PACIENTES PEDIáTRICOS". A presente invenção provê uma fórmula pediátrica aperfeiçoada e métodos para prover nutrição e melhorar a tolerância em pacientes pediátricos. A fórmula pode ser provida em formas de pó, concentrado, ou prontas para o consumo. A fórmula pediátrica compreende, com base em uma base de 100 Kcal, de cerca de 8 a cerca de 16 gramas de carboidrato (preferivelmente de cerca de 9, 4 a 12, 3 gramas), de cerca de 3 a cerca de 6 gramas de lipídeo (preferivelmente de cerca de 4, 7 a cerca de 5,6 gramas), de cerca de 1,8 a cerca de 3,3 gramas de proteína (preferivelmente de cerca de 2, 4 a cerca de 3,3 gramas) e um melhorador de tolerância, que compreende de cerca de 37 a cerca de 370 miligramas (preferivelmente de cerca de 74 a cerca de 222 miligramas, mais preferivelmente de cerca de 111 a cerca de 148 miligramas) de goma xantano. A fórmula pode ser provida em um pó, que compreende, com base em 100 gramas de pó, de cerca de 30 a cerca de 90 gramas de carboidrato (preferivelmente de cerca de 48 a cerca de 59), de cerca de 15 a cerca de 30 gramas de lipídeo (preferivelmente de 22 a cerca de 28 gramas), de cerca de 8 a cerca de 17 gramas de proteína (preferivelmente de cerca de 11 a cerca de 17), e de cerca de 188 a cerca de 1880 miligramas (preferivelmente de cerca de 375 a cerca de 1125, mais preferivelmente de cerca de 375 a cerca de 1125 miligramas) de goma xantano. A fórmula compreende ainda preferivelmente vitaminas e minerais e pode ainda compreender um estabilizador. Os métodos compreende administrar a um paciente pediátrico uma quantidade efetiva de uma fórmula pediátrica de acordo com a invenção, como acima descrito.
BR0106681-1A 2000-02-04 2001-01-16 Fórmula pediátrica e métodos para prover nutrição a pacientes pediátricos e para melhorar tolerância em pacientes pediátricos BR0106681A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/498,350 US6365218B1 (en) 2000-02-04 2000-02-04 Pediatric formula and methods for providing nutrition and improving tolerance
PCT/US2001/001295 WO2001056406A1 (en) 2000-02-04 2001-01-16 Improved pediatric formula and methods for providing nutrition and improving tolerance

Publications (1)

Publication Number Publication Date
BR0106681A true BR0106681A (pt) 2002-04-30

Family

ID=23980707

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0106681-1A BR0106681A (pt) 2000-02-04 2001-01-16 Fórmula pediátrica e métodos para prover nutrição a pacientes pediátricos e para melhorar tolerância em pacientes pediátricos

Country Status (28)

Country Link
US (2) US6365218B1 (pt)
EP (1) EP1251750B1 (pt)
JP (1) JP2003521501A (pt)
KR (1) KR100767202B1 (pt)
CN (1) CN1400870A (pt)
AT (1) ATE321462T1 (pt)
AU (1) AU780438B2 (pt)
BG (1) BG107019A (pt)
BR (1) BR0106681A (pt)
CA (1) CA2396148C (pt)
CY (1) CY1108033T1 (pt)
CZ (1) CZ20022743A3 (pt)
DE (1) DE60118387T2 (pt)
DK (1) DK1251750T3 (pt)
ES (1) ES2261432T3 (pt)
HK (1) HK1050983B (pt)
HU (1) HUP0204382A3 (pt)
IL (1) IL150326A (pt)
MX (1) MXPA02006938A (pt)
NO (1) NO20023684L (pt)
NZ (1) NZ519695A (pt)
PL (1) PL357134A1 (pt)
PT (1) PT1251750E (pt)
SI (1) SI21018A (pt)
SK (1) SK12562002A3 (pt)
TR (1) TR200201921T2 (pt)
TW (1) TWI241167B (pt)
WO (1) WO2001056406A1 (pt)

Families Citing this family (146)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6365218B1 (en) * 2000-02-04 2002-04-02 Abbott Laboratories Pediatric formula and methods for providing nutrition and improving tolerance
SE520688C2 (sv) * 2000-04-11 2003-08-12 Bone Support Ab Ett injicerbart ersättningsmaterial för benmineral
SE517168C2 (sv) * 2000-07-17 2002-04-23 Bone Support Ab En komposition för ett injicerbart ersättningsmaterial för benmineral
US6716466B2 (en) * 2001-01-17 2004-04-06 Nestec S.A. Balanced food powder composition
US20040121044A1 (en) * 2001-03-14 2004-06-24 John Tiano Nutritional product with high protein, low carbohydrate content and good physical stability
US6808736B2 (en) * 2001-06-07 2004-10-26 Nestec S.A. Soy hydrolysate based nutritional formulations
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US20060039958A1 (en) * 2003-05-28 2006-02-23 Monosolrx, Llc. Multi-layer films having uniform content
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US20030099753A1 (en) * 2001-11-20 2003-05-29 Yang Baokang Juice based beverage compositions
SE522098C2 (sv) * 2001-12-20 2004-01-13 Bone Support Ab Ett nytt benmineralsubstitut
US8367098B2 (en) 2002-04-30 2013-02-05 The Population Council, Inc. Unique combinations of antimicrobial compositions
US7070825B2 (en) 2002-09-10 2006-07-04 Abbott Laboratories Infant formula
SE0300620D0 (sv) * 2003-03-05 2003-03-05 Bone Support Ab A new bone substitute composition
US20040214791A1 (en) * 2003-04-25 2004-10-28 Nancy Auestad High lactose infant nutrition formula
DE10339180A1 (de) * 2003-08-21 2005-03-24 Deutsche Gelatine-Fabriken Stoess Ag Kollagenhydrolysat
WO2005023018A1 (en) * 2003-09-10 2005-03-17 Unilever N.V. Food composition
NO319624B1 (no) * 2003-09-15 2005-09-05 Trouw Internat Bv Fiskefôr for laksefisk i ferskvann og anvendelse av slikt fôr.
SE0302983D0 (sv) * 2003-11-11 2003-11-11 Bone Support Ab Anordning för att förse spongiöst ben med benersättnings- och/eller benförstärkningsmaterial och förfarande i samband därmed
US20050276762A1 (en) * 2004-06-15 2005-12-15 Tapas Das Topical compositions containing 5'-adenosine-diphosphate ribose
SE527528C2 (sv) 2004-06-22 2006-04-04 Bone Support Ab Anordning för framställning av härdbar massa samt användning av anordningen
EP2335921A1 (en) 2004-09-30 2011-06-22 MonoSolRX, LLC Multi-layer films
US20060251634A1 (en) 2005-05-06 2006-11-09 Ho-Jin Kang Method of improving immune function in mammals using lactobacillus strains with certain lipids
WO2006130027A1 (en) * 2005-05-31 2006-12-07 Santos Ma Joyce Bedelia B Aqueous oral liquid vitamin supplements containing stabilized vitamin c and metal ions
US20060286208A1 (en) * 2005-06-01 2006-12-21 Nagendra Rangavajla Methods for producing protein partial hydrolysates and infant formulas containing the same
US7618669B2 (en) * 2005-06-01 2009-11-17 Mead Johnson Nutrition Company Low-lactose partially hydrolyzed infant formula
US20070166354A1 (en) * 2005-10-26 2007-07-19 Bridget Barrett-Reis Method of reducing the risk of retinopathy of prematurity in preterm infants
US7829126B2 (en) 2005-10-26 2010-11-09 Abbott Laboratories Infant formulas containing docosahexaenoic acid and lutein
US20070134395A1 (en) * 2005-12-13 2007-06-14 Hodges Everett L Method of reducing manganese in defatted soy isolate
US20070166411A1 (en) * 2005-12-16 2007-07-19 Bristol-Myers Squibb Company Nutritional supplement containing long-chain polyunsaturated fatty acids
US7691547B2 (en) * 2006-03-16 2010-04-06 Microtome Precision, Inc. Reticle containing structures for sensing electric field exposure and a method for its use
US20070281054A1 (en) * 2006-05-31 2007-12-06 Abbott Laboratories Organic powder nutritional formula containing select carbohydrate combinations
EP1867237A1 (en) * 2006-06-15 2007-12-19 Nestec S.A. Hypoallergenic Egg
US20080026105A1 (en) * 2006-07-28 2008-01-31 Bristol-Myers Squibb Company Nutritional formulations containing octenyl succinate anhydride-modified tapioca starch
US8722120B2 (en) * 2006-08-02 2014-05-13 Mead Johnson Nutrition Company Amino acid-based nutritional formulations
CN100463681C (zh) * 2006-10-24 2009-02-25 北京紫竹药业有限公司 一种治疗干眼症的人工泪液
CA2705145A1 (en) 2007-11-07 2009-05-14 Mead Johnson Nutrition Company Method for decreasing bitterness and improving taste of protein-free and hydrolyzed infant formulas
US8329642B1 (en) 2007-11-14 2012-12-11 Gans Eugene H Formula and method to enhance external physiognomy
CN101877972B (zh) * 2007-11-20 2014-07-09 荷兰纽迪希亚公司 处理刺槐豆胶粉
US9131721B2 (en) * 2007-12-04 2015-09-15 Nestec S.A. Gut microbiota in infants
US8361534B2 (en) * 2007-12-20 2013-01-29 Abbott Laboratories Stable nutritional powder
AU2008343689A1 (en) 2007-12-20 2009-07-09 Abbott Laboratories Stable nutritional powder
US20100068346A1 (en) * 2008-09-16 2010-03-18 Hodges Everett L Infant formula
RU2521642C2 (ru) * 2008-10-20 2014-07-10 Нестек С.А. Питательная композиция с противосрыгивающими свойствами
IT1392084B1 (it) * 2008-12-12 2012-02-09 Marzullo Composizione immuno-nutrizionale
WO2010100370A1 (fr) † 2009-03-02 2010-09-10 Roquette Freres Poudre granulee de lait vegetal, procede d'obtention du lait vegetal et ses utilisations
WO2010126353A1 (en) * 2009-04-27 2010-11-04 N.V. Nutricia Pea-based protein mixture and use thereof in a liquid nutritional composition suitable for enteral feeding
TW201112967A (en) * 2009-09-16 2011-04-16 Abbott Lab Dryblended nutritional powders
TW201121431A (en) 2009-12-01 2011-07-01 Abbott Lab Soy protein-based nutritional formula with superior stability
TWI492744B (zh) * 2009-12-04 2015-07-21 Abbott Lab 使用類胡蘿蔔素調節早產兒發炎症之方法
CA2785262A1 (en) * 2009-12-22 2011-07-21 Nestec S.A. Nutritional compositions and methods for optimizing dietary acid-base potential
NZ601141A (en) 2010-01-19 2014-07-25 Abbott Lab Nutritional formulas containing synbiotics
CN102711522B (zh) 2010-01-29 2015-09-09 雅培制药有限公司 包含hmb的无菌包装的营养液
SG182812A1 (en) 2010-01-29 2012-09-27 Abbott Lab Nutritional emulsions comprising calcium hmb
US9693577B2 (en) 2010-01-29 2017-07-04 Abbott Laboratories Method of preparing a nutritional powder comprising spray dried HMB
US9180137B2 (en) 2010-02-09 2015-11-10 Bone Support Ab Preparation of bone cement compositions
TWI526161B (zh) 2010-06-10 2016-03-21 亞培公司 包含鈣ｈｍｂ及可溶性蛋白質之實質上透明營養液
EP2397038A1 (en) 2010-06-21 2011-12-21 Abbott Laboratories Early programming of brain function through soy protein feeding
EP2404507A1 (en) * 2010-07-08 2012-01-11 Nestec S.A. Array of age-tailored nutritional formula with optimum fat content
WO2012009426A1 (en) 2010-07-13 2012-01-19 Abbott Laboratories High tolerance infant formula including hydrolyzed protein
EP2422629A1 (en) 2010-08-23 2012-02-29 Abbott Laboratories Methods for enhancing cognition and/or memory using maltodextrins
WO2012027285A1 (en) 2010-08-24 2012-03-01 Abbott Laboratories Nutritional products having improved organoleptic properties
WO2012027287A1 (en) 2010-08-24 2012-03-01 Abbott Laboratories Nutritional products including pea protein hydrolysates
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
FI123201B (fi) * 2010-10-29 2012-12-14 Valio Oy Maitopohjainen tuote ja valmistusmenetelmä
FR2968895B1 (fr) * 2010-12-17 2013-04-12 United Pharmaceuticals Composition anti-regurgitation et/ou anti-reflux gastro-oesophagien, preparation et utilisations
ES2875458T3 (es) 2010-12-29 2021-11-10 Abbott Lab Producto nutricional para uso en la reducción de la incidencia de enterocolitis necrosante en un lactante, niño pequeño o niño
EP2658397A1 (en) * 2010-12-30 2013-11-06 Abbott Laboratories Improved tolerance in a low calorie infant formula
WO2012092083A1 (en) * 2010-12-30 2012-07-05 Abbott Laboratories Improved rate of protein digestion in a low calorie infant formula
NZ612099A (en) * 2010-12-30 2015-02-27 Abbott Lab Low calorie infant formula with improved physical attributes
CN103501638A (zh) 2010-12-31 2014-01-08 雅培制药有限公司 包含人乳低聚糖和核苷酸的营养型组合物以及其治疗和/或预防肠病毒感染的用途
CN103763940B (zh) 2010-12-31 2015-10-14 雅培制药有限公司 促进有益微生物群生长的益生菌和人乳寡糖的合益素组合
US9283240B2 (en) 2010-12-31 2016-03-15 Abbott Laboratories Human milk oligosaccharides for modulating inflammation
SG10201707519PA (en) 2010-12-31 2017-10-30 Abbott Lab Neutral human milk oligosaccharides to promote growth of beneficial bacteria
MY171620A (en) 2010-12-31 2019-10-21 Abbott Lab Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers or children using human milk oligosaccharides
MX338174B (es) 2010-12-31 2016-04-06 Abbott Lab Metodos para reducir la incidencia de la tension oxidativa al usar los oligosacaridos de leche humana, la vitamina c y los agentes antiinflamatorios.
MY166945A (en) 2010-12-31 2018-07-25 Abbott Lab Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof
CA2822495C (en) 2010-12-31 2020-12-22 Abbott Laboratories Methods of using human milk oligosaccharides for improving airway respiratory health
WO2013012989A2 (en) 2011-07-19 2013-01-24 The Trustees Of Columbia University In The City Of New York Method and system for production of hydrogen and carbon monoxide
WO2013016111A1 (en) 2011-07-22 2013-01-31 Abbott Laboratories Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
MX2011007872A (es) 2011-07-26 2013-01-29 Nucitec Sa De Cv Composicion nutrimental para niños que presentan reflujo, colico y/o estreñimiento.
MX368124B (es) 2011-08-29 2019-09-19 Abbott Lab Oligosacaridos de leche humana para prevenir lesion y/o promover cicatrizacion del tracto gastrointestinal.
MX356589B (es) 2011-09-20 2018-06-05 Abbott Lab Formulaciones nutricionales en polvo que incluyen proteina vegetal secada por aspersion.
WO2013101516A1 (en) 2011-12-29 2013-07-04 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using extracted genomic dna
BR112014016310A8 (pt) 2011-12-29 2017-07-04 Abbott Lab métodos para reduzir a contaminação microbiana de composições nutricionais em pó produzidas por mistura a seco
US10849334B2 (en) 2012-02-01 2020-12-01 Koninklijke Douwe Egberts B.V. Dairy mineral-fortified liquid dairy products and methods for making the dairy mineral-fortified liquid dairy products
US10834935B2 (en) 2012-02-01 2020-11-17 Koninklijke Douwe Egberts B.V. Dairy mineral-fortified liquid dairy products and methods of making
WO2013133691A1 (en) * 2012-03-09 2013-09-12 N.V. Nutricia Liquid nutritional composition comprising free amino acids
SG11201406022YA (en) 2012-03-27 2014-10-30 Abbott Lab Methods for modulating cell-mediated immunity using human milk oligosaccharides
KR102049131B1 (ko) * 2012-03-30 2019-11-26 가부시키가이샤 오츠카 세이야쿠 고죠 유화 식품 조성물
WO2013170189A1 (en) 2012-05-11 2013-11-14 Abbott Laboratories Combination of beta - hydroxy - beta - methylbutyrate and beta - alanine for increasing muscle blood flow
DK2708145T3 (en) 2012-09-14 2016-07-18 Abbott Lab Nutritional Compositions for Use in Methods to Modulate Corticosterone Levels in Psychologically Stressed Individuals
ES2795665T3 (es) 2012-09-14 2020-11-24 Abbott Lab Procedimientos para aumentar la funcionalidad cerebral utilizando 2-fucosil-lactosa
EP2708146A1 (en) 2012-09-17 2014-03-19 Abbott Laboratories, Inc. Nutritional composition for pregnant women with a beneficial glucose and insulin profile
WO2014078544A1 (en) 2012-11-14 2014-05-22 Abbott Laboratories Compositions and methods for improving the long term safety of powdered infant formulas
WO2014099904A1 (en) 2012-12-17 2014-06-26 Abbott Laboratories Methods for enhancing motor function, enhancing functional status and mitigating muscle weakness in a subject
MY187609A (en) 2012-12-18 2021-10-04 Abbott Lab Human milk oligosaccharides to ameliorate symptoms of stress
EP2745705A1 (en) 2012-12-18 2014-06-25 Abbott Laboratories Nutritional use of human milk oligosaccharides
WO2014100022A1 (en) 2012-12-18 2014-06-26 Abbott Laboratories Dietary oligosaccharides to enhance learning and memory
CN104853621A (zh) 2012-12-20 2015-08-19 雅培制药有限公司 使用人乳寡糖用于调节炎症的营养制剂
EP2745708A1 (en) 2012-12-24 2014-06-25 Abbott Laboratories, Inc. Antidepressant effect of ß-hydroxy-ß-methylbutyrate
TR201807495T4 (tr) 2013-02-20 2018-06-21 Bone Support Ab Sertleştirilebilir kemik ikamesine yönelik geliştirilmiş katılaştırma.
US20140242216A1 (en) * 2013-02-24 2014-08-28 Mead Johnson Nutrition Company Amino Acid And Protein Hydrolysate Based Formulas With A Stable Emulsion System
JP2016510603A (ja) 2013-03-12 2016-04-11 アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ 多機能型粘度調整剤を含む組成物
CN105188417B (zh) 2013-03-15 2017-08-08 雅培制药有限公司 包括β‑羟基‑β‑甲基丁酸钙、酪蛋白磷酸肽和蛋白质的营养组合物
US20140271979A1 (en) * 2013-03-15 2014-09-18 Mead Johnson Nutrition Company Anti-regurgitation nutritional composition
MX2015013000A (es) 2013-03-15 2015-12-01 Abbott Lab Metodos de mantenimiento y mejora de la funcion muscular.
FR3005392B1 (fr) * 2013-05-07 2015-09-18 United Pharmaceuticals Composition anti-regurgitation preservant le transit intestinal
EP3007690A1 (en) 2013-06-10 2016-04-20 Abbott Laboratories Methods and compositions for enhancing cognitive performance
WO2015048646A1 (en) 2013-09-30 2015-04-02 Abbott Laboratories Protein powder
IN2015DN03236A (pt) 2013-10-11 2015-10-02 Abbott Lab
US10568896B2 (en) 2013-11-19 2020-02-25 Abbott Laboratories Methods for preventing or mitigating acute allergic responses using human milk oligosaccharides
EP2888950A1 (en) 2013-12-24 2015-07-01 Abbott Laboratories Methods for treating, preventing, or reducing neuroinflammation or cognitive impairment
WO2015105981A2 (en) 2014-01-09 2015-07-16 Abbott Laboratories Conditional essentiality of hmb
EP3129030A1 (en) 2014-04-08 2017-02-15 Abbott Laboratories Methods for enhancing mucosal innate immune responses to and/or detection of pathogens using human milk oligosaccharides
WO2016061486A1 (en) * 2014-10-16 2016-04-21 Cargill, Incorporated Process for preparing a directly compressible erythritol & uses thereof
CN104489660A (zh) * 2014-12-10 2015-04-08 常州兆阳光能科技有限公司 富硒低糖营养保健液
CN104544092A (zh) * 2015-01-29 2015-04-29 王维义 一种亚麻籽油微囊粉及其制备工艺
WO2016126215A1 (en) * 2015-02-03 2016-08-11 Jirapinyo Pipop Amino acid-based formula and production process thereof
US10039805B1 (en) 2016-02-26 2018-08-07 Michelle Ann Toothman Infant formulas having vitamin complexes with enhanced bioavailability
US11122833B1 (en) 2016-02-26 2021-09-21 Michelle Ann Toothman Infant formulas having vitamin complexes with enhanced bioavailability
US10617700B1 (en) 2016-02-26 2020-04-14 Michelle Ann Toothman Vitamin supplement compositions with enhanced bioavailability
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
KR20190005199A (ko) 2016-05-05 2019-01-15 어퀘스티브 테라퓨틱스, 아이엔씨. 강화된 전달 에프네프린 조성물
SE542106C2 (en) * 2016-08-26 2020-02-25 Atif M Dabdoub Dietary macro/micronutritional supplement for patients undergoing kidney dialysis
US20190261670A1 (en) * 2016-09-13 2019-08-29 Nestec S.A. Infant formula for cow's milk protein allergic infants
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
WO2020222248A1 (en) * 2019-05-02 2020-11-05 Nuflower Foods And Nutrition Private Limited Ready to use food compositions and a method of making the same
WO2020247225A1 (en) 2019-06-07 2020-12-10 Abbott Laboratories Nutritional ingredient with flow and antifoam properties
JP2023520558A (ja) 2020-04-06 2023-05-17 アボット・ラボラトリーズ 呼吸器系誘導性サイトカインを調節する栄養処方剤
KR102594730B1 (ko) * 2020-09-21 2023-10-26 숙명여자대학교산학협력단 농축 유청 단백질 및 검류 혼합물로 이루어진 점도증진용 조성물
WO2022177965A1 (en) 2021-02-16 2022-08-25 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and bovine immunoglobulin
WO2022226311A1 (en) 2021-04-23 2022-10-27 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and a designed lipid component for improving lung function
WO2022266058A1 (en) 2021-06-14 2022-12-22 Abbott Laboratories Methods and compositions for treating gas
WO2023159093A1 (en) 2022-02-16 2023-08-24 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and bovine immunoglobulin
WO2024064327A1 (en) 2022-09-22 2024-03-28 Abbott Laboratories Human milk oligosaccharides for enhancing blood-brain barrier function
WO2024089061A1 (en) 2022-10-25 2024-05-02 N.V. Nutricia Thickened formula for allergic infants
WO2024089060A1 (en) * 2022-10-25 2024-05-02 N.V. Nutricia Antiregurgitation formula

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4282262A (en) 1980-03-04 1981-08-04 General Mills, Inc. Dairy based mixes for frozen desserts and method of preparation
EP0045158A1 (en) 1980-07-17 1982-02-03 Merck & Co. Inc. Process for thickening and stabilizing oil in water emulsions containing milk solids and emulsion stabilizer for use therein
US4670268A (en) 1985-01-29 1987-06-02 Abbott Laboratories Enteral nutritional hypoallergenic formula
DD294404A5 (de) * 1989-09-18 1991-10-02 Akademie Der Wissenschaften,De Verfahren zur herstellung von trockenmischungen fuer die zubereitung von fett-in-wasser-emulsionen fuer lebensmittelzwecke
US5171602A (en) 1990-06-13 1992-12-15 Kraft General Foods, Inc. Non-fat frozen dairy product
CH681343A5 (pt) 1990-10-26 1993-03-15 Nestle Sa
US5256436A (en) 1992-05-14 1993-10-26 The Coca-Cola Company Ready to serve frozen dessert for soft serve dispensing
FR2699370B1 (fr) * 1992-12-17 1995-01-13 Cedilac Sa Procédé pour la fabrication d'un lait infantile liquide prêt à l'emploi longue conservation et anti-régurgitation, et lait ainsi obtenu.
US5472952A (en) 1993-03-18 1995-12-05 Bristol-Myers Squibb Company Partially hydrolyzed pectin in nutritional compositions
US5376396A (en) 1993-04-27 1994-12-27 Merck & Co., Inc. Beverage stabilizing system and process thereof
JP3510376B2 (ja) 1995-03-16 2004-03-29 太陽化学株式会社 安定な乳飲料の製造法
US5597595A (en) 1995-04-07 1997-01-28 Abbott Laboratories Low pH beverage fortified with calcium and vitamin D
US5817351A (en) 1995-04-07 1998-10-06 Abbott Laboratories Calcium fortified low pH beverage
US5609897A (en) 1995-04-07 1997-03-11 Abbott Laboratories Powdered beverage concentrate or additive fortified with calcium and vitamin D
US6099871A (en) * 1995-06-01 2000-08-08 Bristol-Myers Squibb Company Anti-regurgitation infant formula
US5827544A (en) * 1995-10-10 1998-10-27 The Arab Pharmaceutical Manufacturing Co. Ltd. Different way of management of neonatal hyperbilirubinemia
CA2240260C (en) 1995-12-15 2002-11-12 The Procter & Gamble Company Beverages having stable flavor/cloud emulsions in the presence of polyphosphate-containing preservative systems and low levels of xanthan gum
US5681600A (en) 1995-12-18 1997-10-28 Abbott Laboratories Stabilization of liquid nutritional products and method of making
DE69714734T2 (de) 1996-04-09 2003-04-24 Du Pont Isoflavon angereichertes sojaeiweissprodukt und verfahren zur herstellung
US6365218B1 (en) * 2000-02-04 2002-04-02 Abbott Laboratories Pediatric formula and methods for providing nutrition and improving tolerance

Also Published As

Publication number Publication date
JP2003521501A (ja) 2003-07-15
MXPA02006938A (es) 2003-01-28
US6365218B1 (en) 2002-04-02
CA2396148A1 (en) 2001-08-09
HK1050983B (zh) 2006-10-27
WO2001056406A1 (en) 2001-08-09
PL357134A1 (en) 2004-07-12
US6589576B2 (en) 2003-07-08
CA2396148C (en) 2011-09-06
US20020176911A1 (en) 2002-11-28
IL150326A (en) 2005-06-19
BG107019A (bg) 2003-04-30
SK12562002A3 (sk) 2002-12-03
NO20023684L (no) 2002-10-02
HK1050983A1 (en) 2003-07-18
AU2949001A (en) 2001-08-14
EP1251750A1 (en) 2002-10-30
AU780438B2 (en) 2005-03-24
IL150326A0 (en) 2002-12-01
PT1251750E (pt) 2006-08-31
NO20023684D0 (no) 2002-08-02
HUP0204382A3 (en) 2004-07-28
TR200201921T2 (tr) 2003-01-21
KR100767202B1 (ko) 2007-10-17
HUP0204382A2 (hu) 2003-04-28
DE60118387D1 (de) 2006-05-18
DE60118387T2 (de) 2006-12-07
ES2261432T3 (es) 2006-11-16
SI21018A (sl) 2003-04-30
CZ20022743A3 (cs) 2002-11-13
CY1108033T1 (el) 2013-09-04
NZ519695A (en) 2004-10-29
DK1251750T3 (da) 2006-08-07
ATE321462T1 (de) 2006-04-15
KR20020075787A (ko) 2002-10-05
TWI241167B (en) 2005-10-11
EP1251750B1 (en) 2006-03-29
CN1400870A (zh) 2003-03-05

Similar Documents

Publication Publication Date Title
BR0106681A (pt) Fórmula pediátrica e métodos para prover nutrição a pacientes pediátricos e para melhorar tolerância em pacientes pediátricos
ES2262202T3 (es) Uso de acido 5-metil- (6s)-tetrahidrofolico para la prevencion de defectos del tubo neural.
IL135335A0 (en) Method for inhibiting or preventing hormone induced adverse effects and novel pharmaceutical compositions comprising carotenoids
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
BR0308799A (pt) co-glóbulos de dha e alecrim e método de uso
MX9605940A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
HUP9803044A2 (hu) Ibuprofentartalmú készítmény
DE69519300T2 (de) Stabiles arzneimittel enthaltend oxaliplatin
EA200501203A1 (ru) Жидкие фармацевтические композиции палоносетрона
DK1383752T3 (da) Deutererede 3-piperidinopropiophenoner samt lægemidler indeholdende disse forbindelser
BR0308713A (pt) Co-esférula de dha e alecrim, e métodos de uso
BR0211198A (pt) Composições farmacêuticas e seu uso
KR970025615A (ko) 암 전이 억제제
Hardy et al. Nutraceuticals: a pharmaceutical viewpoint: I
WO2003002125A3 (en) Combination of aminosugars and cysteine or cysteine derivatives
BR9904890A (pt) "compostos de heteroetinileno, composição farmacêutica, composição cosmética e utilização de uma composição cosmética"
PL367812A1 (en) Alpha-ketoglutarates of active ingredients and compositions containing same
PT1202956E (pt) Derivados terapeuticos e/ou nuricionalmente melhorados de ingredientes activos e composicoes de administracao oral contendo o mesmo
AU2001289762A1 (en) Pharmaceutical extemporary compositions
BR0014233A (pt) Conjugados de 4-benzilaminoquinolina com ácido galênico e seus heteroanálogos, processos para a sua preparação, medicamentos contendo estes compostos e sua aplicação
BRPI0411436A (pt) composição, suplemento dietético, composição farmacêutica, e, métodos de tratamento para cáncer de fìgado, para danos ao fìgado causados por quimioembolização, e de um distúrbio do sistema hepatobiliar, e para cirrose e hepatite de fìgado
ES2375391B1 (es) Composición de complemento nutricional.
LT2006062A (lt) Elementinės sieros vaistiniai produktai, skirti su glutationo s transferazės fermentu susijusioms ligoms gydyti
YU87302A (sh) Inhibitori 11-beta-hidroksi steroidne dehidrogenaze, tip 1
TH61362A (th) องค์ประกอบทางเภสัชกรรม

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A,7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2014 DE 11/08/2009.

B15K Others concerning applications: alteration of classification

Ipc: A23L 33/18 (2016.01), A23L 29/269 (2016.01), A23L